Top Markets
Coin of the day
Valerio Therapeutics S.A. Valerio Therapeutics S.A.

Valerio Therapeutics S.A.

ALVIO
Ранг среди акций #14050
Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A.... Headquartered in Paris, France, and founded in 1997, Valerio Therapeutics S.A. (known as Onxeo SA until June 2023) is a clinical-stage biotechnology company dedicated to the global research and development of oncology treatments. Their focus is on targeting the DNA repair processes crucial for tumor survival. The company's offerings include Beleodaq, an approved medication for peripheral T-cell lymphoma. Their development pipeline features AsiDNA, which is progressing through Phase 1 clinical trials for metastatic melanoma and is also being evaluated for relapsed ovarian cancer through a research collaboration with Gustave Roussy. Furthermore, Valerio Therapeutics is advancing OX401, a preclinical program targeting DNA damage response and immuno-oncology, along with its proprietary platON decoy oligonucleotide platform. The firm also holds a licensing agreement with Acrotech Biopharma LLC.
Цена акции
$0.88012714
Последняя синхронизация: 2026-08-31
Рыночная капитализация
$439.58M
Изменение (1 день)
-4.01%
Изменение (1 год)
1,131.97%
Страна
FR
Торговля Valerio Therapeutics S.A. (ALVIO)

Категория

Коэффициент P/B для Valerio Therapeutics S.A. (ALVIO)
Коэффициент P/B на 2026 TTM: 0
Согласно последним финансовым отчетам и цене акций Valerio Therapeutics S.A., текущий коэффициент P/B (TTM) составляет 0. В конце 2026 он составлял 0.
История P/B для Valerio Therapeutics S.A. с 2026 по 2026
Коэффициент P/B в конце каждого года
Год P/B Изменить
Недостаточно данных для указанных дат.
Коэффициент P/B для аналогичных компаний или конкурентов
Компания P/B Разница P/B Страна
6.3419 -
US
6.2413 -
NL
2.5054 -
AU
3.7087 -
US
- -
CH